Midwestern and Southern states consistently carry the highest burden
These compounds, also called glucocorticosteroids, such as prednisone, dexamethasone, and triamcinolone, are prohibited in competition due to their metabolic and anti-inflammatory effects
All compounded formulations are prepared by Olympia Pharmaceuticals under cGMP guidelines and with oversight by national and state pharmacy boards
Wellbutrin (bupropion alone) is approved for depression and seasonal affective disorder, not weight loss
In October 2019, the United States Food and Drug Administration (FDA) approved MT1 under the brand name Scenesse for increasing sunlight tolerance and alleviating pain from ultraviolet (UV) light exposure in patients with erythropoietic protoporphyria (EPP) [4]
2018 $32 million jury verdict on behalf of a North Texas woman who had been sexually assaulted in 2012 at the age of 14